Company intelligence / Profile preview

iuvo BioScience

Rochester, New York, USAiuvobioscience.com ↗

Ownership: Private
Employees: ~59
Development stage: Commercial

Overview

iuvo BioScience does not develop its own therapeutics but provides comprehensive preclinical and clinical research services for ophthalmic medical device and pharmaceutical companies. It has supported studies across a wide range of anterior and posterior segment eye diseases.

Therapeutic areas: Ophthalmology
Modalities: Device (ophthalmic devices)Small molecule (pharmaceuticals for ophthalmology)Biologic (if applicable to ophthalmic drugs/devices tested)Combination product (drugs + devices in ophthalmology)
Industry: Contract Research Organization

Partnerships

Ampersand Capital Partners (private equity backer)strategic partnership with Canyon Labs post-acquisition of lab/consulting divisions

Beyond the preview

Go deeper on iuvo BioScience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on iuvo BioScience.

Explore the full profile